1- Tirzepatide Drug Information- UpToDate [April 2025]
2- Tirzepatide. FDA Label, Revised: 02/2025.
3- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
4- Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet. 2023 Aug 19;402(10402):613-26.
5- Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021 Aug 5;385(6):503-15.
6- Zepbound® (tirzepatide) Injection [Internet]. Lilly.com. Eli Lilly and Company; 2019. Available from: https://zepbound.lilly.com/hcp/clinical-data-weight
7- A1C and Weight Change Results | Mounjaro® (tirzepatide) [Internet]. Lilly.com. 2024. Available from: https://mounjaro.lilly.com/hcp/a1c-weight
‌

‌